A group of shareholders in life sciences company eSense-Lab has requisitioned a general meeting to remove three directors, including chief executive Haim Cohen, while also seeking to appoint MMJ Phytotech managing director Andreas Gedeon and Otsana Capital founder Faldi Ismail to the board.
A group of shareholders in life sciences company eSense-Lab has requisitioned a general meeting to remove three directors, including chief executive Haim Cohen, while also seeking to appoint MMJ Phytotech managing director Andreas Gedeon and Otsana Capital founder Faldi Ismail to the board.
The three shareholders include Netherlands-based Attollo Investments, Buzz Capital and Romfal Sifat.
The group has proposed resolutions to remove Mr Cohen and non-executive directors Eran Gilboa and Ilan Saad.
Along with the proposed appointments, the group is seeking the reappointment of Brendan de Kauwe, who is also a director at Otsana Capital, as chairman of the company.
MMJ invested $500,000 into eSense in November last year to take a 3.5 per cent share in the company.
The company said in a statement to the ASX that the board was currently considering its obligations and would update the market in due course.
eSense, which is headquartered in Israel, listed on the ASX in February last year and has developed plant profiling technology that can be used to generate a comprehensive model of targeted plants.
The model is used to reverse engineer and reconstruct the plant’s profile using alternate natural sources, in what it says is a more cost-effective and sustainable way.
Its primary focus is on the cannabis plant.
Shares in eSense were unchanged at the close.
